Evaluation of renal protective effects of inhibiting TGF-β type I receptor in a cisplatin-induced nephrotoxicity model

European Cytokine Network

Volumn 24, Issue 4, 2013, Pages 139-147

  Bayomi, Hala S ^a   Elsherbiny, Nehal M ^a   El Gayar, Amal M ^a   Al Gayyar, Mohammed M H ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Caspase 3; Cisplatin; MDA; SB 431542; sCD93; SOD; TGF 1; TGF R1

Indexed keywords

4 [4 (1, 3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL] BENZAMIDE; CASPASE 3; CISPLATIN; CYTOKINE; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOMERULUS FILTRATION; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY PARENCHYMA; MALE; MORPHOLOGY; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; RAT; RENAL PROTECTION; UREA BLOOD LEVEL;

CASPASE-3; CISPLATIN; MDA; SB-431542; SCD93; SOD; TGF-Β1; TGF-ΒR1;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZAMIDES; CASPASE 3; CISPLATIN; DIOXOLES; KIDNEY; KIDNEY DISEASES; MALE; MALONDIALDEHYDE; MEMBRANE GLYCOPROTEINS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, COMPLEMENT; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84896961294     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2014.0344     Document Type: Article

References (39)

1. Braud AC, Gonzague L, Bertucci F, et al. Retinoids, cisplatin and interferon-alpha in recurrent or metastatic cervical squamous cell carcinoma: clinical results of 2 phase II trials. Eur Cytokine Netw 2002; 13: 115-20.
2. El-Mowafy AM, Salem HA, Al-Gayyar MM, El-Mesery ME, El-Azab MF. Evaluation of renal protective effects of the greentea (EGCG) and red grape resveratrol: role of oxidative stress and inflammatory cytokines. Nat Prod Res 2011; 25: 850-6.
3. El-Mowafy AM, Al-Gayyar MM, Salem HA, El-Mesery ME, Darweish MM. Novel chemotherapeutic and renal protective effects for the green tea (EGCG): role of oxidative stress and inflammatorycytokine signaling. Phytomedicine 2010; 17: 1067-75.
4. El-Mowafy AM, El-Mesery ME, Salem HA, Al-Gayyar MM, Darweish MM. Prominent chemopreventive and chemoenhancing effects for resveratrol: unraveling molecular targets and the role of C-reactive protein. Chemotherapy 2010; 56: 60-5.
5. Dashti-Khavidaki S, Moghaddas A, Heydari B, Khalili H, Lessan-Pezeshki M. Statins against drug-induced nephrotoxicity. J Pharm Pharm Sci 2013; 16: 588-608.
6. Trujillo J, Chirino YI, Molina-Jijon E, Anderica-Romero AC, Tapia E, Pedraza-Chaverri J. Renoprotective effect of the antioxidant curcumin: Recent findings. Redox Biol 2013; 1: 448-56.
7. Ramesh G, Reeves WB. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 2002; 110: 835-42.
8. Wong SW, Tiong KH, Kong WY, et al. Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through upregulation of p73. Breast Cancer Res Treat 2011; 128: 301-13.
9. Perez-Rojas JM, Cruz C, Garcia-Lopez P, et al. Renoprotection by alpha-Mangostin is related to the attenuation in renal oxidative/ nitrosative stress induced by cisplatin nephrotoxicity. Free Radic Res 2009; 43: 1122-32.
10. Chou JL, Su HY, Chen LY, et al. Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer. Lab Invest 2010; 90: 414-25.
11. Chen YX, Wang Y, Fu CC, et al. Dexamethasone enhances cell resistance to chemotherapy by increasing adhesion to extracellular matrix in human ovarian cancer cells. Endocr Relat Cancer 2010; 17: 39-50.
12. Callahan JF, Burgess JL, Fornwald JA, et al. Identification of novel inhibitors of the transforming growth factor beta1 (TGF-beta1) type 1 receptor (ALK5). J Med Chem 2002; 45: 999-1001.
13. Inman GJ, Nicolas FJ, Callahan JF, et al. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 2002; 62: 65-74.
14. El-Mesery M, Al-Gayyar M, Salem H, Darweish M, El-Mowafy A. Chemopreventive and renal protective effects for docosahexaenoic acid (DHA): implications of CRP and lipid peroxides. Cell Div 2009; 4: 6.
15. Atessahin A, Yilmaz S, Karahan I, Ceribasi AO, Karaoglu A. Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats. Toxicology 2005; 212: 116-23.
16. Waghabi MC, de Souza EM, de Oliveira GM, et al. Pharmacological inhibition of transforming growth factor beta signaling decreases infection and prevents heart damage in acute Chagas disease. Antimicrob Agents Chemother 2009; 53: 4694-701.
17. Schindeler A, Morse A, Peacock L, et al. Rapid cell culture and preclinical screening of a transforming growth factor-beta (TGF-beta) inhibitor for orthopaedics. BMC Musculoskelet Disord 2010; 11: 105.
18. Kelly DJ, Edgley AJ, Zhang Y, et al. Protein kinase C-beta inhibition attenuates the progression of nephropathy in non-diabetic kidney disease. Nephrol Dial Transplant 2009; 24: 1782-90.
19. Elsherbiny NM, Abd El Galil KH, Gabr MM, Al-Gayyar MM, Eissa LA, El-Shishtawy MM. Reno-protective effect of NECA in diabetic nephropathy: implication of IL-18 and ICAM-1. Eur Cytokine Netw 2012; 23: 78-86.
20. Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 1978; 90: 37-43.
21. DeChatelet LR, McCall CE, McPhail LC, Johnston Jr. RB. Superoxide dismutase activity in leukocytes. J Clin Invest 1974; 53: 1197-11201.
22. Pezeshki Z, Nematbakhsh M, Mazaheri S, et al. Estrogen Abolishes Protective Effect of Erythropoietin against Cisplatin-Induced Nephrotoxicity in Ovariectomized Rats. ISRN Oncol 2012: 890310.
23. Dobyan DC, Levi J, Jacobs C, Kosek J, Weiner MW. Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations. J Pharmacol Exp Ther 1980; 213: 551-6.
24. Xin J, Homma T, Matsusaka T, et al. Suppression of cyclosporine a nephrotoxicity in vivo by transforming growth factor beta receptor-immunoglobulin G chimeric protein. Transplantation 2004; 77: 1433-42.
25. Wang Y, Zhang Z, Shen H, et al. TGF-beta1/Smad7 signaling stimulates renal tubulointerstitial fibrosis induced by AAI. J Recept Signal Transduct Res 2008; 28: 413-28.
26. Vijayan FP, Rani VK, Vineesh VR, Sudha KS, Michael MM, Padikkala J. Protective effect of Cyclea peltata Lam on cisplatininduced nephrotoxicity and oxidative damage. J Basic Clin Physiol Pharmacol 2007; 18: 101-14.
27. Yamada T. [Studies on the mechanisms of renal damages induced by nephrotoxic compounds]. Nihon Hoigaku Zasshi 1995; 49: 447-57.
28. Yao X, Panichpisal K, Kurtzman N, Nugent K. Cisplatin nephrotoxicity: a review. Am J Med Sci 2007; 334: 115-24.
29. Lu Q, Zhai Y, Cheng Q, et al. The Akt-FoxO3a-manganese superoxide dismutase pathway is involved in the regulation of oxidative stress in diabetic nephropathy. Exp Physiol 2013; 98: 934-45.
30. Dickler HB, Kunkel HG. Interaction of aggregated globulin with B lymphocytes. J Exp Med 1972; 136: 191-6.
31. Tenner AJ. C1q interactions with cell surface receptors. Behring Inst Mitt: 1989; 220-9.
32. Ghebrehiwet B. Functions associated with the C1q receptor. Behring Inst Mitt: 1989; 204-15.
33. Boyer Arnold N, Korc M. Smad7 abrogates transforming growth factor-beta1-mediated growth inhibition in COLO-357 cells through functional inactivation of the retinoblastoma protein. J Biol Chem 2005; 280: 21858-66.
34. Jablonska E, Wawrusiewicz-Kurylonek N, Garley M, et al. A proliferation-inducing ligand (APRIL) in neutrophils of patients with oral cavity squamous cell carcinoma. Eur Cytokine Netw 2012; 23: 93-100.
35. Wrana JL, Attisano L, Carcamo J, et al. TGF beta signals through a heteromeric protein kinase receptor complex. Cell 1992; 71: 1003-14.
36. Kaushal GP, Kaushal V, Hong X, Shah SV. Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells. Kidney Int 2001; 60: 1726-36.
37. Lau AH. Apoptosis induced by cisplatin nephrotoxic injury. Kidney Int 1999; 56: 1295-8.
38. Halder SK, Beauchamp RD, Datta PK. A specific inhibitor of TGFbeta receptor kinase, SB-431542, as a potent antitumor agent for human cancers. Neoplasia 2005; 7: 509-21.
39. Spender LC, Carter MJ, O'Brien DI, et al. Transforming growth factor-beta directly induces p53-up-regulated modulator of apoptosis (PUMA) during the rapid induction of apoptosis in myc-driven B-cell lymphomas. J Biol Chem 2013; 288: 5198-209.